Nmp4/CIZ: Road block at the intersection of PTH and load

Bone

Volumn 46, Issue 2, 2010, Pages 259-266

  Childress, Paul ^a   Robling, Alexander G ^a,b   Bidwell, Joseph P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Indiana University Purdue University Indianapolis   (United States)

Author keywords

Architectural transcription factor; Mechanosome; Nuclear matrix; Osteoblast; Osteoporosis

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BETA CATENIN; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN TYPE 1; COLLAGENASE 3; CRK ASSOCIATED SUBSTRATE INTERACTING ZINC FINGER PROTEIN; CRK ASSOCIATED SUBSTRATE PROTEIN; DNA; HIGH MOBILITY GROUP B1 PROTEIN; LYMPHOID ENHANCER FACTOR 1; NUCLEAR MATRIX PROTEIN; NUCLEAR MATRIX PROTEIN 4; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; SCLEROSTIN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZYXIN;

BONE CELL; BONE DENSITY; BONE MASS; BONE MINERAL; CELL ADHESION; CELL FUNCTION; CELL NUCLEUS; CELL SHAPE; COLLAGEN SYNTHESIS; CYTOPLASM; DNA CONFORMATION; DRUG APPROVAL; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG POTENTIATION; EDITORIAL; EXERCISE; FOOD AND DRUG ADMINISTRATION; GENE TARGETING; HUMAN; MECHANICAL STRESS; MECHANOTRANSDUCTION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRABECULAR BONE; TREATMENT OUTCOME; WEIGHT BEARING;

ANIMALS; BONE RESORPTION; INTEGRINS; MECHANOTRANSDUCTION, CELLULAR; MICE; NUCLEAR MATRIX-ASSOCIATED PROTEINS; PARATHYROID HORMONE; TERIPARATIDE; TRANSCRIPTION FACTORS; WEIGHT-BEARING;

EID: 74249089194     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.09.014     Document Type: Editorial

References (71)

1. Allen M.R., and Burr D.B. Mineralization, microdamage and matrix: how bisphosphonates influence material properties of bone. BoneKEy-Osteovision 4 (2007) 49-60
2. Alvarez M., Long H., Onyia J., Hock J., Xu W., and Bidwell J. Rat osteoblast and osteosarcoma nuclear matrix proteins bind with sequence specificity to the rat type I collagen promoter. Endocrinology 138 (1997) 482-489
3. Alvarez M., Rhodes S.J., and Bidwell J.P. Context-dependent transcription: all politics is local. Gene 313 (2003) 43-57
4. Alvarez M., Shah R., Rhodes S.J., and Bidwell J.P. Two promoters control the mouse Nmp4/CIZ transcription factor gene. Gene 347 (2005) 43-54
5. Alvarez M., Thunyakitpisal P., Morrison P., Onyia J., Hock J., and Bidwell J.P. PTH-responsive osteoblast nuclear matrix architectural transcription factor binds to the rat type I collagen promoter. J. Cell. Biochem. 69 (1998) 336-352
6. Alvarez M.B., Thunyakitpisal P., Rhodes S.J., Everett E.T., and Bidwell J.P. Assignment of Nmp4 to mouse chromosome 6 band F1 flanked by D6Mit134 and D6Mit255 using radiation hybrid mapping and fluorescence in situ hybridization. Cytogenet. Cell Genet. 94 3-4 (2001) 244-245
7. Bellido T., Ali A.A., Plotkin L.I., Fu Q., Gubrij I., Roberson P.K., et al. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J. Biol. Chem. 278 (2003) 50259-50272
8. Bidwell J.P., Alvarez M., Feister H., Onyia J., and Hock J. Nuclear matrix proteins and osteoblast gene expression. J. Bone Miner. Res. 13 (1998) 155-167
9. Bidwell J.P., Yang J., and Robling A.G. Is HMGB1 an osteocyte alarmin. J. Cell Biochem. 103 (2008) 1671-1680
10. Blick S.K., Dhillon S., and Keam S.J. Teriparatide: a review of its use in osteoporosis. Drugs 68 (2008) 2709-2737
11. Bogdanovic Z., Huang Y.F., Dodig M., Clark S.H., Lichtler A.C., and Kream B.E. Parathyroid hormone inhibits collagen synthesis and the activity of rat col1a1 transgenes mainly by a cAMP-mediated pathway in mouse calvariae. J. Cell Biochem. 77 (2000) 149-158
12. Bouxsein M.L., Pierroz D.D., Glatt V., Goddard D.S., Cavat F., Rizzoli R., et al. Beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice. J. Bone Miner. Res. 20 4 (2005) 635-643
13. Carlsson P., Waterman M.L., and Jones K.A. The hLEF/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in T cells. Genes Dev. 7 (1993) 2418-2430
14. Case N., Ma M., Sen B., Xie Z., Gross T.S., and Rubin J. Beta-catenin levels influence rapid mechanical responses in osteoblasts. J. Biol. Chem. 283 (2008) 29196-29205
15. Cattaruzza M., Lattrich C., and Hecker M. Focal adhesion protein zyxin is a mechanosensitive modulator of gene expression in vascular smooth muscle cells. Hypertension 43 (2004) 726-730
16. Charoonpatrapong-Panyayong K., Shah R., Yang J., Alvarez M., Pavalko F.M., Gerard-O'Riley R., et al. Nmp4/CIZ contributes to fluid shear stress induced MMP-13 gene induction in osteoblasts. J. Cell. Biochem. 102 (2007) 1202-1213
17. Davies J., and Chambers T.J. Parathyroid hormone activates adhesion in bone marrow stromal precursor cells. J. Endocrinol. 180 (2004) 505-513
18. Defilippi P., Di Stefano P., and Cabodi S. p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol. 16 (2006) 257-263
19. Dhawan J., Lichtler A.C., Rowe D.W., and Farmer S.R. Cell adhesion regulates pro-alpha 1(I) collagen mRNA stability and transcription in mouse fibroblasts. J. Biol. Chem. 266 (1991) 8470-8475
20. Dodig M., Kronenberg M.S., Bedalov A., Kream B.E., Gronowicz G., Clark S.H., et al. Identification of a TAAT-containing motif required for high level expression of the COL1A1 promoter in differentiated osteoblasts of transgenic mice. J. Biol. Chem. 271 (1996) 16422-16429
21. Egan J.J., Gronowicz G., and Rodan G.A. Parathyroid hormone promotes the disassembly of cytoskeletal actin and myosin in cultured osteoblastic cells: mediation by cyclic AMP. J. Cell. Biochem. 45 (1991) 101-111
22. Feister H.A., Torrungruang K., Thunyakitpisal P., Parker G.E., Rhodes S.J., and Bidwell J.P. NP/NMP4 transcription factors have distinct osteoblast nuclear matrix subdomains. J. Cell. Biochem. 79 (2000) 506-517
23. Feister H.A., Onyia J.E., Miles R.R., Yang X., Galvin R., Hock J.M., et al. The expression of the nuclear matrix proteins NuMA, topoisomerase II-alpha, and-beta in bone and osseous cell culture: regulation by parathyroid hormone. Bone 26 (2000) 227-234
24. Ferrari S.L., Pierroz D.D., Glatt V., Goddard D.S., Bianchi E.N., Lin F.T., et al. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2. Endocrinology 146 (2005) 1854-1862
25. Fuchs R.K., and Warden S.J. Combination therapy using exercise and pharmaceutical agents to optimize bone health clinic. Rev. Bone Miner. Metab. 6 (2008) 37-45
26. Gieni R.S., and Hendzel M.J. Mechanotransduction from the ECM to the genome: are the pieces now in place?. J. Cell. Biochem. 104 (2008) 1964-1987
27. Glass II D.A., Bialek P., Ahn J.D., Starbuck M., Patel M.S., Clevers H., et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell. 8 (2005) 751-764
28. Goto K., Heymont J.L., Klein-Nulend J., Kronenberg H.M., and Demay M.B. Identification of an osteoblastic silencer element in the first intron of the rat osteocalcin gene. Biochemistry 35 (1996) 11005-11011
29. Guignandon A., Lafage-Proust M.H., Usson Y., Laroche N., Caillot-Augusseau A., Alexandre C., et al. Cell cycling determines integrin-mediated adhesion in osteoblastic ROS 17/2.8 cells exposed to space-related conditions. FASEB J. 15 (2001) 2036-2061
30. Hino K., Nakamoto T., Nifuji A., Morinobu M., Yamamoto H., Ezura Y., et al. Deficiency of CIZ, a nucleocytoplasmic shuttling protein, prevents unloading-induced bone loss through the enhancement of osteoblastic bone formation in vivo. Bone 40 (2007) 852-860
31. Hirata H., Tatsumi H., and Sokabe M. Mechanical forces facilitate actin polymerization at focal adhesions in a zyxin-dependent manner. J. Cell Sci. 121 (2008) 2795-2804
32. Ho A.M., Marker P.C., Peng H., Quintero A.J., Kingsley D.M., and Huard J. Dominant negative Bmp5 mutation reveals key role of BMPs in skeletal response to mechanical stimulation. BMC Dev. Biol. 8 (2008) 35
33. Horikawa A., Okada K., Sato K., and Sato M. Morphological changes in osteoblastic cells (MC3T3-E1) due to fluid shear stress: cellular damage by prolonged application of fluid shear stress. Tohoku J. Exp. Med. 2000 191 (2000) 127-137
34. Hughes-Fulford M., Rodenacker K., and Jütting U. Reduction of anabolic signals and alteration of osteoblast nuclear morphology in microgravity. J. Cell. Biochem. 99 (2006) 435-449
35. Janssen H., and Marynen P. Interaction partners for human ZNF384/CIZ/NMP4-zyxin as a mediator for p130CAS signaling?. Exp. Cell Res. 312 (2006) 1194-1204
36. Jilka R.L. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40 (2007) 1434-1446
37. Jin H., Van't Hof R.J., Albagha O.M., and Ralston S.H. Promoter and intron 1 polymorphisms of COL1A1 interact to regulate transcription and susceptibility to osteoporosis. Hum. Mol. Genet. 18 (2009) 2729-2738
38. Kim W., Seok Kang Y., Soo Kim J., Shin N.Y., Hanks S.K., and Song W.K. The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-beta signaling. Mol. Biol. Cell. 19 (2008) 2135-2146
39. Kramer I., Loots G.G., Studer A., Keller H., and Kneissel M. Parathyroid hormone (PTH) induced bone gain is blunted in SOST overexpressing and deficient mice. J. Bone Miner. Res. (2009) 2009 Jul 13. [Epub ahead of print]
40. Krebsbach P.H., Harrison J.R., Lichtler A.C., Woody C.O., Rowe D.W., and Kream B.E. Transgenic expression of COL1A1-chloramphenicol acetyltransferase fusion genes in bone: differential utilization of promoter elements in vivo and in cultured cells. Mol. Cell. Biol. 13 (1993) 5168-5174
41. Kulkarni N.H., Halladay D.L., Miles R.R., Gilbert L.M., Frolik C.A., Galvin R.J., et al. Effects of parathyroid hormone on Wnt signaling pathway in bone. J. Cell. Biochem. 95 (2005) 1178-1190
42. Lenga Y., Koh A., Perera A.S., McCulloch C.A., Sodek J., and Zohar R. Osteopontin expression is required for myofibroblast differentiation. Circ. Res. 102 (2007) 319-327
43. Li F., Li B., Wang Q.M., and Wang J.H. Cell shape regulates collagen type I expression in human tendon fibroblasts. Cell Motil. Cytoskeleton 65 (2008) 332-341
44. Maniotis A.J., Chen C.S., and Ingber D.E. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 849-854
45. Matthews J.L., and Talmage R.V. Influence of parathyroid hormone on bone cell ultrastructure. Clin. Orthop. Relat. Res. 156 (1981) 27-38
46. Misteli T. Beyond the sequence: cellular organization of genome function. Cell 128 (2007) 787-800
47. Morinobu M., Nakamoto T., Hino K., Tsuji K., Shen Z.J., Nakashima K., et al. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation. J. Exp. Med. 201 (2005) 961-970
48. Mosekilde L. Primary hyperparathyroidism and the skeleton. Clin. Endocrinol. (Oxf). 69 (2008) 1-19
49. Nakamoto T., Yamagata T., Sakai R., Ogawa S., Honda H., Ueno H., et al. CIZ, a zinc finger protein that interacts with p130(cas) and activates the expression of matrix metalloproteinases. Mol. Cell. Biol. 20 (2000) 1649-1658
50. Pavalko F.M., Norvell S.M., Burr D.B., Turner C.H., Duncan R.L., and Bidwell J.P. A model for mechanotransduction in bone cells: the load-bearing mechanosomes. J. Cell. Biochem. 88 (2003) 104-112
51. Philip B., Childress P., Robling A., Heller A., and Bidwell J.P. ASBMR 31st Annual Meeting September 11-15, 2009 Denver, Colorado, USA SU0107 (2009)
52. Robling A.G., Childress P., Yu J., Cotte J., Heller A., Philip B.K., et al. Nmp4/CIZ suppresses parathyroid hormone-induced increases in trabecular bone. J. Cell. Physiol. 219 (2009) 734-743
53. Rowe D.W. Viewing problems in bone biology from the perspective of lineage identification. J. Musculoskelet. Neuronal Interact. 5 (2005) 350-352
54. Rubin J., Rubin C., and Jacobs C.R. Molecular pathways mediating mechanical signaling in bone. Gene 367 (2006) 1-16
55. Sato M.M., Nakashima A., Nashimoto M., Yawaka Y., and Tamura M. Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression. Genes Cells 14 (2009) 141-153
56. Sawada Y., Tamada M., Dubin-Thaler B.J., Cherniavskaya O., Sakai R., Tanaka S., et al. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 127 (2006) 1015-1026
57. Shah R., Alvarez M., Jones D.R., Torrungruang K., Watt A.J., Selvamurugan N., et al. Nmp4/CIZ regulation of matrix metalloproteinase 13 (MMP-13) response to parathyroid hormone in osteoblasts. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E289-E296
58. Shen Z.J., Nakamoto T., Tsuji K., Nifuji A., Miyazono K., Komori T., et al. Negative regulation of bone morphogenetic protein/Smad signaling by Cas-interacting zinc finger protein in osteoblasts. J. Biol. Chem. 277 (2002) 29840-29846
59. Sowa H., Kaji H., Iu M.F., Tsukamoto T., Sugimoto T., and Chihara K. Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblasts. J. Biol. Chem. 278 (2003) 52240-52252
60. Sparvero L.J., Asafu-Adjei D., Kang R., Tang D., Amin N., Im J., et al. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J. Transplant. Med. 7 (2009) 17
61. Sugiyama T., Saxon L.K., Zaman G., Moustafa A., Sunters A., Price J.S., et al. Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice. Bone 43 (2008) 238-248
62. Thomas C.H., Collier J.H., Sfeir C.S., and Healy K.E. Engineering gene expression and protein synthesis by modulation of nuclear shape. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 1972-1977
63. Thunyakitpisal P., Alvarez M., Tokunaga K., Onyia J.E., Hock J., Ohashi N., et al. Cloning and functional analysis of a family of nuclear matrix transcription factors (NP/NMP4) that regulate type I collagen expression in osteoblasts. J. Bone Miner. Res. 16 (2001) 10-23
64. Torrungruang K., Alvarez M., Shah R., Onyia J.E., Rhodes S.J., and Bidwell J.P. DNA binding and gene activation properties of the Nmp4 nuclear matrix transcription factors. J. Biol. Chem. 277 (2002) 16153-16159
65. Torrungruang K., Feister H., Swartz D., Hancock E.B., Hock J., and Bidwell J.P. Parathyroid hormone regulates the expression of the nuclear mitotic apparatus protein in the osteoblast-like cells, ROS 17/2.8. Bone 22 (1998) 317-324
66. Turner C.H. Bone strength: current concepts. Ann. N. Y. Acad. Sci. 1068 (2006) 429-446 Review
67. Turner R.T., Evans G.L., Lotinun S., Lapke P.D., Iwaniec U.T., and Morey-Holton E. Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats. J. Bone Miner. Res. 22 (2007) 64-71
68. Turner R.T., Lotinun S., Hefferan T.E., and Morey-Holton E. Disuse in adult male rats attenuates the bone anabolic response to a therapeutic dose of parathyroid hormone. J. Appl. Physiol. 101 (2006) 881-886
69. Woo C.H., Shishido T., McClain C., Lim J.H., Li J.D., Yang J., et al. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells. Circ. Res. 102 5 (2008) 538-545 Epub 2008 Jan 24
70. Zhang J., Ryder K.D., Bethel J.A., Ramirez R., and Duncan R.L. PTH-induced actin depolymerization increases mechanosensitive channel activity to enhance mechanically stimulated Ca2+signaling in osteoblasts. J. Bone Miner. Res. 21 (2006) 1729-1737
71. Stewart C.L., Roux K.J., and Burke B. Blurring the boundary: the nuclear envelope extends its reach. Science 318 (2007) 1408-1412